DOCSLIB.ORG

1 Neuroanatomical Correlates of Child

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

NEUROANATOMICAL CORRELATES OF CHILD BEHAVIOR CHECKLIST AGGRESSIVE BEHAVIOR SCORES IN TYPICALLY DEVELOPING CHILDREN Simon Ducharme MD (260287392) Department of Psychiatry McGill University, Montréal Manuscript‐Based Thesis submitted on September 2011 “A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of M.Sc. in Psychiatry” ©Simon Ducharme, 2011 1 TABLE OF CONTENTS 1. English Abstract……………………………………………………………..3 2. Résumé en français…………………………………………………………5 3. Acknowledgements………………………………………………………...7 4. Preface……………………………………………………………………….....10 4.1 Definitions………………………………………………………..10 4.2 Neurobiology of Aggression……………………………….13 4.3 Anterior Cingulate Cortex………………………………….16 4.4 Orbito‐Frontal Cortex………………………………………..16 5. Rationale of the Research………………………………………………18 5. Contributions of Authors………………………………………………..22 6. Manuscript…………………………………………………………………….23 6.1 Introduction………………………………………………………25 6.2 Methods…………………………………………………………….28 6.3 Results…………………………………………………………...….33 6.4 Discussion………………………………………………………….36 6.5 Acknowledgements and Disclosures……………………42 6.6 Tables and Figures……………………………………………...43 6.7 Supplemental Material………………………………………..48 7. Postface………………………………………………………………………….55 7.1 Integrative Models……………………………………………...60 8. Final Conclusions…………………………………………………………….65 9. Elements of Originality.……………………………………………………66 10. References……………………………………………………………………67 2 ENGLISH ABSTRACT Background: The anterior cingulate cortex (ACC), orbito‐frontal cortex (OFC) and basal ganglia have been implicated in the neurobiology of pathological aggression. They are thought to be the structures involved in top‐down regulation of impulses from the limbic system. This study aimed at identifying neuroanatomical correlates of impulsive aggression in healthy children. Methods: Data from 193 representative 6‐18 year‐old healthy children were obtained from the NIH MRI Study of Normal Brain Development after a blinded quality control (1). Cortical thickness and subcortical volumes were obtained with automated software. Aggression levels were measured with the Aggressive Behavior scale (AGG) of the Child Behavior Checklist (CBCL). AGG scores were regressed against cortical thickness and basal ganglia volumes using first and second‐order linear models while controlling for age, gender, scanner site and total brain volume. ‘Gender by AGG’ interactions were analyzed. Whole brain random field theory corrections for multiple comparisons were implemented. Results: There were positive associations between bilateral striatal volumes and AGG scores (right: r=0.238, p=0.001; left: r=0.188, p=0.01). A significant association was found with right ACC and subgenual ACC cortical thickness in a second‐order linear model (p<0.05, corrected). High AGG scores were associated with a relatively 3 thin right ACC cortex. An ‘AGG by gender’ interaction trend was found in bilateral OFC and ACC associations with AGG scores. Conclusion: This study shows the existence of relationships between impulsive aggression in healthy children and the structure of the striatum and right ACC. It also suggests the existence of gender specific patterns of association in OFC/ACC grey matter. These results may guide research on oppositional‐defiant and conduct disorders. KEYWORDS: Aggression, Cortical Thickness, Anterior Cingulate Cortex, Orbito‐ Frontal Cortex, Striatum, Magnetic Resonance Imaging (MRI) 4 RÉSUMÉ EN FRANÇAIS Contexte: Le cortex cingulaire antérieur (CCA), le cortex orbito‐frontal (COF) et les noyaux gris centraux ont été identifiés dans les recherches sur la neurobiologie de l’agressivité pathologique. Ces structures seraient impliquées dans la régulation ‘top­down’ des impulsions produites dans le système limbique. Le but de cette étude était d’identifier les corrélations neuroanatomiques de l’agressivité impulsive chez les enfants en santé ayant un développement normal. Méthodologie: Les données de 193 sujets de 6 à 18 ans ont été obtenues de l’étude NIH MRI Study of Normal Brain Development après un contrôle visuel de qualité des données (1). L’épaisseur corticale et les volumes sous‐corticaux ont été obtenus avec des programmes automatisés. Le niveau d’agressivité a été mesuré avec l’échelle de comportements agressifs (AGG) obtenue du questionnaire Child Behavior Checklist. Les scores de AGG ont été analysés en régression linéaire avec l’épaisseur corticale et le volume des noyaux gris centraux en utilisant des modèles de premier et de deuxième ordre, et en contrôlant pour les effets de l’âge, du sexe, du numéro de scanner et du volume cérébral total. L’interaction ‘AGG X sexe’ a aussi été analysée. Une correction statistique de type random field theory pour comparaisons multiples a été appliquée aux résultats. 5 Résultats: Une association positive a été trouvée entre les scores de AGG et le volume du striatum bilatéralement (droite: r=0.238, p=0.001; gauche: r=0.188, p=0.01). Une association significative était aussi présente entre AGG et l’épaisseur corticale du CCA droit et du CCA sous‐géniculé droit dans un modèle linéaire de deuxième ordre (p<0.05, corrigé). Les scores AGG élevés étaient associés à un CCA droit relativement mince. Une tendance d’association entre l’épaisseur corticale et l’interaction ‘AGG X sexe’ a aussi été trouvée dans le COF et le CCA bilatéralement. Conclusion: Cette étude démontre l’existence d’une relation entre l’agressivité impulsive chez les enfants en santé et la structure anatomique du striatum, ainsi que du CCA droit. Elle suggère également l’existence de patterns d’associations spécifiques au sexe dans la matière grise du COF et du CCA. Ces résultats pourraient guider la recherche clinique sur le trouble oppositionnel avec provocation et le trouble des conduites. MOTS CLÉS: Agressivité, Épaisseur corticale, Cortex cingulaire antérieur, Cortex orbito‐frontal, Striatum, Imagerie par résonance magnétique (IRM) 6 ACKNOWLEDGEMENTS The design of the NIH MRI Study of Normal Brain Development and data collection were performed by a multisite network called the Brain Development Cooperative Group*, which includes the Montreal Neurological Institute as the Data Coordinating Centre. The design of the current study on impulsive aggression and statistical analyses described in the manuscript were performed by the author of this thesis under the supervision of Dr. Sherif Karama and Dr. Alan C. Evans. The author acknowledges the help and support of other members of the McConnell Brain Imaging Centre, including Dr. Claude Lepage (member of staff), Dr. D. Louis Collins (member of staff), Samir Das (member of staff), Dr. Hooman Ganjavi (fellow student) and Dr. Tuong‐Vi Nguyen (fellow student). There were no research assistants involved in this study. The author also wants to thank US collaborators including Dr. James J. Hudziak and Matthew D. Albaugh at the University of Vermont, in addition to Dr. Kelly N. Botteron at Washington University for their intellectual contribution to the design of the study and editorial review of the submitted manuscript. Finally, the author wants to recognize Dr. Sherif Karama and Dr. Alan C. Evans for their close supervision and precious advices at every steps of this masters’ project. 7 *Brain Development Cooperative Group Key personnel from the six pediatric study centers are as follows: Children’s Hospital Medical Center of Cincinnati, Principal Investigator William S. Ball, M.D., Investigators Anna Weber Byars, Ph.D., Mark Schapiro, M.D., Wendy Bommer, R.N., April Carr, B.S., April German, B.A., Scott Dunn, R.T.; Children’s Hospital Boston, Principal Investigator Michael J. Rivkin, M.D., Investigators Deborah Waber, Ph.D., Robert Mulkern, Ph.D., Sridhar Vajapeyam, Ph.D., Abigail Chiverton, B.A., Peter Davis, B.S., Julie Koo, B.S., Jacki Marmor, M.A., Christine Mrakotsky, Ph.D., M.A., Richard Robertson, M.D., Gloria McAnulty, Ph.D; University of Texas Health Science Center at Houston, Principal Investigators Michael E. Brandt, Ph.D., Jack M. Fletcher, Ph.D., Larry A. Kramer, M.D., Investigators Grace Yang, M.Ed., Cara McCormack, B.S., Kathleen M. Hebert, M.A., Hilda Volero, M.D.; Washington University in St. Louis, Principal Investigators Kelly Botteron, M.D., Robert C. McKinstry, M.D., Ph.D., Investigators William Warren, Tomoyuki Nishino, M.S., C. Robert Almli, Ph.D., Richard Todd, Ph.D., M.D., John Constantino, M.D.; University of California Los Angeles, Principal Investigator James T. McCracken, M.D., Investigators Jennifer Levitt, M.D., Jeffrey Alger, Ph.D., Joseph O’Neil, Ph.D., Arthur Toga, Ph.D., Robert Asarnow, Ph.D., David Fadale, B.A., Laura Heinichen, B.A., Cedric Ireland B.A.; Children’s Hospital of Philadelphia, Principal Investigators Dah‐Jyuu Wang, Ph.D. and Edward Moss, Ph.D., Investigators Robert A. Zimmerman, M.D., and Research Staff Brooke Bintliff, B.S., Ruth Bradford, Janice Newman, M.B.A. The Principal Investigator of the data coordinating center at McGill University is Alan C. Evans, Ph.D., Investigators Rozalia Arnaoutelis, B.S., G. Bruce Pike, Ph.D., D. Louis Collins, 8 Ph.D., Gabriel Leonard, Ph.D., Tomas Paus, M.D., Alex Zijdenbos, Ph.D., and Research Staff Samir Das, B.S., Vladimir Fonov, Ph.D., Luke Fu, B.S., Jonathan Harlap, Ilana Leppert, B.E., Denise Milovan, M.A., Dario Vins, B.C.,, and at Georgetown University, Thomas Zeffiro, M.D., Ph.D. and John Van Meter, Ph.D. Ph.D. Investigators at the Neurostatistics Laboratory, Harvard University/McLean Hospital, Nicholas Lange, Sc.D., and Michael P. Froimowitz, M.S., work with data
Recommended publications
  • History of Alzheimer's Disease

    History of Alzheimer's Disease

    Print ISSN 1738-1495 / On-line ISSN 2384-0757 Dement Neurocogn Disord 2016;15(4):115-121 / https://doi.org/10.12779/dnd.2016.15.4.115 DND REVIEW History of Alzheimer’s Disease Hyun Duk Yang,1,2 Do Han Kim,1 Sang Bong Lee,3 Linn Derg Young,2,4,5 1Harvard Neurology Clinic, Yongin, Korea 2Brainwise Co. Ltd., Yongin, Korea 3Barun Lab Inc., Yongin, Korea 4Department of Business Administration, Cheongju University, Cheongju, Korea 5Boston Research Institute for Medical Policy, Yongin, Korea As modern society ages rapidly, the number of people with dementia is sharply increasing. Direct medical costs and indirect social costs for dementia patients are also increasing exponentially. However, the lack of social awareness about dementia results in difficulties to dementia patients and their families. So, understanding dementia is the first step to remove or reduce the stigma of dementia patients and promote the health of our community. Alzheimer’s disease is the most common form of dementia. The term, ‘Alzheimer’s disease’ has been used for over 100 years since first used in 1910. With the remarkable growth of science and medical technologies, the techniques for diagnosis and treat- ment of dementia have also improved. Although the effects of the current symptomatic therapy are still limited, dramatic improvement is ex- pected in the future through the continued research on disease modifying strategies at the earlier stage of disease. It is important to look at the past to understand the present and obtain an insight into the future. In this article, we review the etymology and history of dementia and pre- vious modes of recognizing dementia.
  • The Tangled Story of Alois Alzheimer

    The Tangled Story of Alois Alzheimer

    Bratisl Lek Listy 2006; 107 (910): 343345 343 TOPICAL REVIEW The tangled story of Alois Alzheimer Zilka N, Novak M Institute of Neuroimmunology, AD Centre of Excellence, Slovak Academy of Sciences, Bratislava, Slovakia. [email protected] Abstract In 1907, Bavarian psychiatrist Alois Alzheimer, who is considered to be a founding father of neuropa- thology, was first to describe the main neuropathologic characteristics of the peculiar disease in the brain of a woman showing progressive dementia when she was in her early 50s. Using a newly deve- loped Bielschowskys silver staining method, Alzheimer observed degenerating neurons with bundles of fibrils (neurofibrillary tangles) and miliary foci of silver-staining deposits scattered over the cortex (senile plaques). In 1910 Emil Kraepelin (Alois Alzheimers superior) coined the term Alzheimers disease to distinguish the presenile form of dementia from the more common senile variant. Alzheimers findings were followed up, and soon a number of reports of similar cases appeared in the literature. During the time, both pathological hallmarks of Alzheimers disease became the gold standard for post-mortem diagnosis of the disease. One hundred years later, dementia of Alzheimers type is con- sidered to be one of the most devastating illnesses of old age. Despite intensive research the cause of the disease still remains elusive (Fig. 2, Ref. 17). Key words: Alzheimers disease, Alois Alzheimer, Augusta D, neurofibrillary tangles, senile plaques. Alois Alzheimer was born in June 14, 1864 in Markbreit am pathology of the nervous system, studying in particular the nor- Main in Southern Germany. He commenced the study of medi- mal and pathological anatomy of the cerebral cortex.
  • Franz Nissl (1860-1919), Noted Neuropsychiatrist and Neuropathologist, Staining the Neuron, but Not Limiting It

    Franz Nissl (1860-1919), Noted Neuropsychiatrist and Neuropathologist, Staining the Neuron, but Not Limiting It

    Dement Neuropsychol 2019 September;13(3):352-355 History Note http://dx.doi.org/10.1590/1980-57642018dn13-030014 Franz Nissl (1860-1919), noted neuropsychiatrist and neuropathologist, staining the neuron, but not limiting it Marleide da Mota Gomes1 ABSTRACT. Franz Alexander Nissl carried out studies on mental and nervous disorders, as a clinician, but mainly as a pathologist, probably the most important of his time. He recognized changes in glial cells, blood elements, blood vessels and brain tissue in general, achieving this by using a special blue stain he himself developed – Nissl staining, while still a medical student. However, he did not accept the neuron theory supported by the new staining methods developed by Camillo Golgi and Santiago Ramón y Cajal. Nissl had worked with the crème de la crème of German neuropsychiatry, including Alois Alzheimer, besides Emil Kraepelin, Korbinian Brodmann and Walther Spielmeyer. He became (1904), Kraepelin’s successor as Professor of Psychiatry and Director of the Psychiatric Clinic, in Heidelberg. Moreover, in 1918, the year before Nissl´s death, Kraepelin offered him a research position as head of the Histopathology Department of the newly founded “Deutsche Forschungsanstalt fur Psychiatrie” of the Max Planck Institute for Psychiatry, in Munich. Key words: Franz Nissl, neuropathology, staining method, neuron theory. FRANZ NISSL (1860-1919), NOTÁVEL NEUROPSIQUIATRA E NEUROPATOLOGISTA, TINGINDO O NEURÔNIO, MAS NÃO O LIMITANDO RESUMO. Franz Alexander Nissl realizou estudos sobre transtornos mentais e nervosos, como clínico, mas principalmente como patologista, provavelmente o mais importante de seu tempo. Ele reconheceu mudanças nas células gliais, elementos sangüíneos, vasos sangüíneos e tecido cerebral em geral, realizando-o por meio de um corante azul especial desenvolvida por ele mesmo – coloração de Nissl, ainda como estudante de medicina.
  • Biography of Alois Alzheimer

    Biography of Alois Alzheimer

    BIOGRAPHY OF ALOIS ALZHEIMER (1864-1915) AOUAD MayaAOUAD Maya Joint masterJoint in neuroscience master in neuroscience Alzheimer's disease is a neurodegenerative disorder. It is characterized clinically by a progressive decline of several cognitive functions and it is the most common cause of dementia. The prevalence of this disease is expected to increase during the next decades because of the increasing of the human age population. It is one of the greatest burdens in modern medicine. The symptoms of Alzheimer's disease were first described in the early 1900s by Emil Kraepelin, a German psychiatrist. The neuropathological features were later described by Alois Alzheimer, another German psychiatrist, who worked in Kraepelin's laboratory. The description of this disease is his most known contribution to Neuroscience. However, the research on this disease represents only a small part of Alzheimer's interests, which also included the histopathology of the cerebral cortex in the mentally ill. Who is Alois Alzheimer and what were the main stages of his carrier? Alois Alzheimer was born on the 14th of June 1864 in Markbreit a small Bavarian village, Southern Germany where his father was notary. Excelling in science at school he studied medicine in Berlin, Tubingen and Wurzburg where he wrote his doctoral theses on ceruminal glands and graduated with a medical degree in 1887. In December 1888 he began his medical career as a resident at the Hospital for the Mentally ill and Epileptics in Frankfurt am Main where he stayed for seven years and was subsequently promoted to senior physician. Later Alzheimer worked seven more years as an assistant physician at the Municipal Hospital for Lunatics and Epileptics also called Asylium in Frankfurt headed by Emil Sioli.
  • Kraepelin Revisited: Schizophrenia from Degeneration to Failed Regeneration

    Kraepelin Revisited: Schizophrenia from Degeneration to Failed Regeneration

    Molecular Psychiatry (2015) 20, 671–676 © 2015 Macmillan Publishers Limited All rights reserved 1359-4184/15 www.nature.com/mp REVIEW Kraepelin revisited: schizophrenia from degeneration to failed regeneration P Falkai1, MJ Rossner1,2, TG Schulze3, A Hasan1, MM Brzózka1, B Malchow1, WG Honer4 and A Schmitt1,5 One hundred years after its conceptual definition as ‘Dementia Praecox’ by Emil Kraepelin, schizophrenia is still a serious psychiatric illness that affects young adults and leads to disability in at least half of patients. The key treatment issue is partial or non-response, especially of negative symptoms. The illness is also associated with different degrees of cognitive dysfunction, particularly in verbal and working memory; the resulting functional impairment may lead to unemployment and an inability to maintain stable relationships. Patients’ cognitive dysfunction led Kraepelin to the assumption that schizophrenia is a form of juvenile dementia caused by a degenerative process of the human brain. Postmortem studies and a plethora of imaging studies do not support the notion of a degenerative process, but such a process is supported by the recently published, largest genome-wide association study on schizophrenia. More than a 100 hits were described, converging on pathways that have a significant role in dopamine metabolism in immune modulation, calcium signalling and synaptic plasticity. This review suggests that research should focus on animal models based on risk genes like transcription factor 4 and study the effects of exposure to environmental stressors relevant for schizophrenia. The use of relevant end points like pre-pulse inhibition or cognitive dysfunction will allow us to gain an understanding of the molecular pathways in schizophrenia and consequently result in improved treatment options, especially for the disabling aspects of this illness.
  • Module 1 Lesson 02: History of Neuroscience Overview

    Module 1 Lesson 02: History of Neuroscience Overview

    Module 1 Lesson 02: History of Neuroscience Overview 1 - Students will be able to state early views of the brain. 2 - Students will be able to explain Galen’s views on ventricular localization of brain function. 3 - Students will be able to explain the ideas set forth by Rene Descartes. 4 - Students will be able to describe contributions towards the notion of electrical signaling in nerves to the brain. 5 -Students will be able to describe the discovery of localization within the cerebral cortex. 6 - Students will be able to explain the Nissl and Golgi stains. 7 - Students will be able to explain the neuron doctrine and its significance. 8 - Students will be able to describe the contributions of Otto Loewi to understanding of neurotransmission. 2 Growing Views of the Brain As history has progressed, our understanding of the brain has continued to develop ● Ancient scholars proposed theories addressing the role of the brain ● Renaissance scholars explored the nature of the mind and experience ● 19 and 20th century scholars studied detailed properties of the nervous system Mind Body Dualism Chris Palmer Science wikipedia Writer Growing Views of the Brain As history has progressed, our understanding of the brain has continued to develop ● Ancient scholars proposed theories addressing the role of the brain ● Renaissance scholars explored the nature of the mind and experience ● 19 and 20th century scholars studied detailed properties of the nervous system Mind Body Dualism Chris Palmer Science wikipedia Writer Early Views of the Brain: 1 Egyptians & The Ancient Greeks Ancient Views of the Brain Hippocrates 500 B.C.
  • Contents 100 Years of MPI-BR 1

    Contents 100 Years of MPI-BR 1

    Friends of the newsletter 1/2014 Max Planck Institute for Brain Research newsletter 1/2014 contents 100 years of MPI-BR 1 Exhibition 2 News from our Institute 3 FeM Mädchenhaus 4 Upcoming Neuroscience Lectures and Symposia Photo: HG Esch Photography HG Esch Photo: 100 years of MPI-BR May 28, we celebrated the official opening of the new Institute‘s building as well as hundred yearson of MPI for Brain Research (MPI-BR) with a morning of talks and the opening of our commemorative exhibit, minds in motion (see below), the unveiling of a commissioned piece of art, Mindscape, by Gayle Chong Kwan (www.gaylechongkwan.com) and a book, minds in motion – 100 years, chronicling the history and future directions of our Institute. The morning talks in the Lecture Hall of the new building included presentations from Boris Rhein (Hessen Minister of Science and Arts), as well as Gunter Henn (architect of the building), Herbert Jäckle (Vice President of the Max Planck Society) and a joint lecture by Wolf Singer and Heinz Wässle (Emeritus Directors at the Institute) about the Institute‘s history. Musical intermezzos were provided by Alex Jacobowitz (www.alexjacobowitz.com) who played the xylophone. For more information please visit our website www.brain.mpg.de/mindsinmotion Impression of the official celebrations Photo: Tracy Yamawaki Tracy Photo: on May 28, 2014 newsletter 1/2014 The Exhibition “minds in motion“ exhibition “100 years of MPI, minds in motion“ was opened theon May 28, 2014. The exhibition is located in the public area of the Max Planck Institute for Brain Research and can be visi- ted during week days between 8.00-18.00 hours.
  • Calbindin-D28k Is a More Reliable Marker of Human Purkinje Cells Than Standard Nissl Stains: a Stereological Experiment Elizabeth R

    Calbindin-D28k Is a More Reliable Marker of Human Purkinje Cells Than Standard Nissl Stains: a Stereological Experiment Elizabeth R

    Journal of Neuroscience Methods 168 (2008) 42–47 Calbindin-D28k is a more reliable marker of human Purkinje cells than standard Nissl stains: A stereological experiment Elizabeth R. Whitney a,∗, Thomas L. Kemper a, Douglas L. Rosene a, Margaret L. Bauman a,b, Gene J. Blatt a a Department of Anatomy and Neurobiology, L-1004, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, United States b Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, United States Received 9 June 2007; received in revised form 5 September 2007; accepted 7 September 2007 Abstract In a study of human Purkinje cell (PC) number, a striking mismatch between the number of PCs observed with the Nissl stain and the number of PCs immunopositive for calbindin-D28k (CB) was identified in 2 of the 10 brains examined. In the remaining eight brains this mismatch was not observed. Further, in these eight brains, analysis of CB immunostained sections counterstained with the Nissl stain revealed that more than 99% Nissl stained PCs were also immunopositive for CB. In contrast, in the two discordant brains, only 10–20% of CB immunopositive PCs were also identified with the Nissl stain. Although this finding was unexpected, a historical survey of the literature revealed that Spielmeyer [Spielmeyer W. Histopathologie des nervensystems. Julius Springer: Berlin; 1922. p. 56–79] described human cases with PCs that lacked the expected Nissl staining intensity, an important historical finding and critical issue when studying postmortem human brains. The reason for this failure in Nissl staining is not entirely clear, but it may result from premortem circumstances since it is not accounted for by postmortem delay or processing variables.
  • The Role of Neuropsychiatrists in Medical Science

    The Role of Neuropsychiatrists in Medical Science

    University of Massachusetts Medical School eScholarship@UMMS Psychiatry Publications and Presentations Psychiatry 2018-03-22 The Role of Neuropsychiatrists in Medical Science Joseph Keating University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/psych_pp Part of the Medical Education Commons, Neurology Commons, Psychiatry Commons, and the Psychiatry and Psychology Commons Repository Citation Keating J, Bakeman D, Claunch J, Benjamin S. (2018). The Role of Neuropsychiatrists in Medical Science. Psychiatry Publications and Presentations. Retrieved from https://escholarship.umassmed.edu/ psych_pp/831 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Psychiatry Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. The Role of Neuropsychiatrists in Medical Science Joseph Keating, M.D. • Delia Bakeman, D.O. • Joshua Claunch M.D. • Sheldon Benjamin, M.D. NEUROPSYCHIATRY DIVISION, UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL Abstract Methods Results Conclusion The re-emergence of neuropsychiatry in the twentieth century We searched PubMed using the terms neuropsychiatry history, Electronic searches yielded 165 articles for review. Using these, Physicians who have trained and/or practiced in both neurology occurred in the context of a history of neuropsychiatric psychiatry and neurology history and cross-referenced physicians, combined with textbooks and interviews, we identified over50 (or neurological sciences) and psychiatry have made major contributions to medical science. In parallel to the growth of scientists, doctors and clinicians in psychiatry and neurology, including neuropsychiatrists who made important contributions to medical contributions to medical science.
  • The Bini–Cerletti Electro-Shock Apparatus

    The Bini–Cerletti Electro-Shock Apparatus

    Medical History, 2011, 55: 407–412 Shocking Waves at the Museum: The Bini–Cerletti Electro-shock Apparatus ALESSANDRO ARUTA* Keywords: Electroshock Apparatus; Electroconvulsive Therapy; Exhi- bition; Scientific Museology; Lucio Bini; Ugo Cerletti The historian of science, Lorraine Daston, has written about things that talk.1 But how much can an artefact in a museum communicate its history to the public? Artefacts in museums speak, but it is not necessarily, or even at all, in the language of their original time and place. Cultural baggage, memories, and imagination all come into play, includ- ing those held by museum curators, and not least those contained within the operational and historical frameworks of such institutions.2 At the Museo di Storia della Medicina della Sapienza at the University of Rome we are organising an exhibition around an arte- fact that more than any other elicits emotive reactions – the Bini–Cerletti apparatus for the administration of electro-shock.3 This prototype of the first ECT machine, along with various historical documents, manuals, and textbooks relating to it, is a valued part of the Museo’s collection. We are proud of it, yet as a display item, it is also some- thing of golden chalice. Leaving aside the ethical question of whether we can (or should) convey to visitors the anxiety and pain of the patients who once submitted to the device, and leaving aside the different loads of historical and contemporary baggage that visitors will bring to it, how can such an object be represented in an historically honest way? This is the problem, for while we might be true to the context of its emergence, within Ó Alessandro Aruta, 2011.
  • Neurosciences in Germany Can

    Neurosciences in Germany Can

    EDITORIAL Neurosciences in Germany Can. J. Neurol. Sci. 1999; 26: 75-76 The article on Neurosciences in the Third Reich: from Ivory Asylum in Frankfurt am Main. In 1901 he moved to Berlin, to Tower to Death Camps1 in this issue reminds us of the prime his- work with Oskar Vogt at the world famous Neurobiology torical example of a scientific establishment shooting itself in the Institute. In 1910 he accepted a post with Robert Gaupp, one of foot: Germany after 1933. Before 1933, Germany was the world Germany’s leading psychiatrists in the Department of Psychiatry epicenter of scientific medicine. After 1933, with Hitler’s acces- at Tübingen. And in 1918 Brodmann became head of the topo- sion to power and the implementation of his antisemitic racial graphic-histologic division of Emil Kraepelin’s recently-founded policies, Germany’s scientific preeminence self-destructed. The German Psychiatry Research Institute in Munich, which would Jewish physicians and scientists who had done so much to give later become the premier neuroscientific institute of the world. German medicine its luster were driven from their posts, forced Had Brodmann not died prematurely of sepsis in August of that into exile, and gassed in concentration camps. At the time in year, he would have had as colleagues at the DFA (as it was 1938 that Nazi Germany invaded Austria, annexing that little known by its German initials Ð today the Max Planck Institute for country to the Third Reich, 65 percent of all physicians in Vienna Psychiatry) such figures as Franz Nissl, whose name is familiar were Jewish.
  • Medicating the Eschatological Body

    Medicating the Eschatological Body

    Medicating the Eschatological Body: Psychiatric Technology for Christian Wayfarers by Warren Anderson Kinghorn Date:_______________________ Approved: ___________________________ Prof. Stanley Hauerwas, Supervisor ___________________________ Prof. Paul Griffiths ___________________________ Prof. Reinhard Huetter ___________________________ Prof. Keith Meador ___________________________ Prof. Allen Verhey Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Theology in the Divinity School of Duke University 2011 ABSTRACT Medicating the Eschatological Body: Psychiatric Technology for Christian Wayfarers by Warren Anderson Kinghorn Date:_______________________ Approved: ___________________________ Prof. Stanley Hauerwas, Supervisor ___________________________ Prof. Paul Griffiths ___________________________ Prof. Reinhard Huetter ___________________________ Prof. Keith Meador ___________________________ Prof. Allen Verhey Dissertation abstract submitted in partial fulfillment of the requirements for the degree of Doctor of Theology in the Divinity School of Duke University 2011 Copyright by Warren Anderson Kinghorn 2011 Abstract Biological psychiatry, the mode of psychiatric practice dedicated to the effective application of medication and other somatic technology in the treatment of mental disorders, is an increasingly powerful conceptual lens by which disfavored experience and behavior is interpreted and through which the relationship of the body to experience and to moral agency is narrated. Psychiatric